BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kang SC, Hwang SJ, Lee SH, Chang FY, Lee SD. Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan. World J Gastroenterol 2005; 11(47): 7494-7498 [PMID: 16437722 DOI: 10.3748/wjg.v11.i47.7494]
URL: https://www.wjgnet.com/1007-9327/full/v11/i47/7494.htm
Number Citing Articles
1
Marco daCosta DiBonaventura, Yong Yuan, Benedicte Lescrauwaet, Gilbert L’Italien, Gordon G. Liu, Isao Kamae, Josephine A. Mauskopf, Yury E. Khudyakov. Multicountry Burden of Chronic Hepatitis C Viral Infection among Those Aware of Their Diagnosis: A Patient SurveyPLoS ONE 2014; 9(1): e86070 doi: 10.1371/journal.pone.0086070
2
Shu-Chuan Chang, Sheng-Shun Yang, Chiu-Chun Chang, Chun-Che Lin, Yueh-Chin Chung, Tsai-Chung Li. Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQHealth and Quality of Life Outcomes 2014; 12(1) doi: 10.1186/1477-7525-12-97
3
D. E. FRANSEN VAN DE PUTTE, K. FISCHER, D. POSTHOUWER, E. P. MAUSER‐BUNSCHOTEN. The burden of HCV treatment in patients with inherited bleeding disordersHaemophilia 2011; 17(5): 791 doi: 10.1111/j.1365-2516.2011.02602.x
4
Ke-Qin Hu, Wei Cui, Susan D Rouster, Kenneth E Sherman. Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individualsWorld Journal of Hepatology 2019; 11(5): 442-449 doi: 10.4254/wjh.v11.i5.442
5
K. K. SNOW, H. L. BONKOVSKY, R. J. FONTANA, H.‐Y. KIM, R. K. STERLING, A. M. DI BISCEGLIE, T. R. MORGAN, J. L. DIENSTAG, M. G. GHANY. Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis CAlimentary Pharmacology & Therapeutics 2010; 31(7): 719 doi: 10.1111/j.1365-2036.2010.04235.x
6
Roberto Nuño Solinís, Patricia Arratibel Ugarte, Ander Rojo, Yuri Sanchez Gonzalez. Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic EvidenceInfectious Diseases and Therapy 2016; 5(4): 491 doi: 10.1007/s40121-016-0134-x
7
Shu-Chuan Chang, Wang-Sheng Ko, Shun-Sheng Wu, Cheng-Yuan Peng, Sheng-Shun Yang. Factors Associated with Quality of Life in Chronic Hepatitis C Patients Who Received Interferon Plus Ribavirin TherapyJournal of the Formosan Medical Association 2008; 107(6): 454 doi: 10.1016/S0929-6646(08)60153-9
8
F. SCHMIDT, G. JANSSEN, G. MARTIN, R. LORENZ, K. LOESCHKE, M. SOYKA, C. FOLWACZNY, M. SCHAEFER. Factors influencing long‐term changes in mental health after interferon‐alpha treatment of chronic hepatitis CAlimentary Pharmacology & Therapeutics 2009; 30(10): 1049 doi: 10.1111/j.1365-2036.2009.04123.x
9
Qing Xie, Jian-Wei Xuan, Hong Tang, Xiao-Guang Ye, Peng Xu, I-Heng Lee, Shan-Lian Hu. Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for ChinaWorld Journal of Hepatology 2019; 11(5): 421-441 doi: 10.4254/wjh.v11.i5.421
10
Bruce Crawford, Chi-Kit Yeung, Erika Tanaka, Matthias Kraemer, Claudia Leteneux. Hepatitis C virus in Asia: utility values based on the Short Form-36 questionnaireExpert Review of Pharmacoeconomics & Outcomes Research 2012; 12(6): 765 doi: 10.1586/erp.12.61
11
Elegance TP Lam, Cindy LK Lam, CL Lai, MF Yuen, Daniel YT Fong, Thomas MK So. Health-related quality of life of Southern Chinese with chronic hepatitis B infectionHealth and Quality of Life Outcomes 2009; 7(1) doi: 10.1186/1477-7525-7-52
12
Renato Daltro-Oliveira, Mychelle Morais-de-Jesus, Karine Miranda Pettersen, Raymundo Paraná, Lucas C. Quarantini. Impact of sustained virologic response on quality of life in chronic HVC carriersAnnals of Hepatology 2013; 12(3): 399 doi: 10.1016/S1665-2681(19)31002-6
13
Patrice Cacoub, Cloe Comarmond, Fanny Domont, Léa Savey, Anne C. Desbois, David Saadoun. Extrahepatic manifestations of chronic hepatitis C virus infectionTherapeutic Advances in Infectious Disease 2016; 3(1): 3 doi: 10.1177/2049936115585942
14
Patrice Cacoub, Laura Gragnani, Cloe Comarmond, Anna Linda Zignego. Extrahepatic manifestations of chronic hepatitis C virus infectionDigestive and Liver Disease 2014; 46: S165 doi: 10.1016/j.dld.2014.10.005
15
Hairui Zhang, Ran Ren, Jinlin Liu, Ying Mao, Guowei Pan, Ke Men, Li Ma. Health-Related Quality of Life among Patients with Hepatitis C Virus Infection: A Cross-Sectional Study in Jianping County of Liaoning Province, ChinaGastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/6716103
16
Fang-Pey Chen, Ching-Mao Chang, Ta-Peng Wu, Jen-Lin Yang, Yen-Ying Kung, Yi-Hsiang Huang, Chien-Wei Su, Keng-Hsin Lan, Shu-Chiung Chiang, Shinn-Jang Hwang. Clinical efficacy of Rong-Yang-Jyh-Gan-Tang on patients with chronic hepatitis C: A double-blinded randomized placebo-controlled crossover studyJournal of Ethnopharmacology 2017; 196: 1 doi: 10.1016/j.jep.2016.12.013
17
Erik J. Groessl, Kimberly R. Weingart, Robert M. Kaplan, Samuel B. Ho. Health-related quality of life in HCV-infected patientsCurrent Hepatitis Reports 2007; 6(4): 169 doi: 10.1007/s11901-007-0020-9
18
Wan-Lin Chen, Wen-Ta Chiu, Ming-Shun Wu, Mei-Huang Hsu, Shin-Han Tsai. Translational Research of Telecare for the Treatment of Hepatitis CBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/195097
19
David Whiteley, Lawrie Elliott, Sarah Cunningham-Burley, Anne Whittaker. Health-Related Quality of Life for individuals with hepatitis C: A narrative reviewInternational Journal of Drug Policy 2015; 26(10): 936 doi: 10.1016/j.drugpo.2015.04.019
20
Ciro Conversano, Claudia Carmassi, Marina Carlini, Giulia Casu, Paola Gremigni, Liliana Dell’Osso. Interferon α Therapy in Patients with Chronic Hepatitis C Infection: Quality of Life and DepressionHematology Reports 2015; 7(1): 5632 doi: 10.4081/hr.2015.5632
21
Somaia M. Ebeid, Safaa H. Ali, Heba Y. Kamel, Ahmed A. Elbaz, Hazem M. El-Hariri. Impact of Post Hepatitis C Chronic Liver Disease and Hepatocellular Carcinoma on Health Related Quality of LifeAdvances in Aging Research 2015; 4(06): 177 doi: 10.4236/aar.2015.46019
22
Ira M. Jacobson, Patrice Cacoub, Luigino Dal Maso, Stephen A. Harrison, Zobair M. Younossi. Manifestations of Chronic Hepatitis C Virus Infection Beyond the LiverClinical Gastroenterology and Hepatology 2010; 8(12): 1017 doi: 10.1016/j.cgh.2010.08.026
23
Roger T. Anderson, Robert W. Baran, Birgitta Dietz, Eric Kallwitz, Pennifer Erickson, Dennis A. Revicki. Development and initial psychometric evaluation of the hepatitis C virus-patient-reported outcomes (HCV-PRO) instrumentQuality of Life Research 2014; 23(2): 561 doi: 10.1007/s11136-013-0505-7
24
Mitsuyuki Suzuki, Toru Ishikawa, Ai Sakuma, Satoshi Abe, Hiroko Abe, Fujiko Koyama, Tomomi Nakano, Aya Ueki, Hirohito Noguchi, Erina Hasegawa, Shiori Yamagata, Miki Kobayashi, Kazutaka Ohashi, Hiroshi Hirosawa, Takako Fukazawa, Yuka Maruyama, Toshiaki Yoshida. Evaluation of the health-related quality of life using the 36-item short form health survey in patients with chronic hepatitis C receiving pegylated interferon/ribavirin/telaprevir triple treatmentExperimental and Therapeutic Medicine 2016; 12(5): 3353 doi: 10.3892/etm.2016.3785
25
Q Zhang. Relationship between quality of life and basic syndromes of traditional Chinese medicine in patients with posthepatitic cirrhosisJournal of Chinese Integrative Medicine 2010; : 30 doi: 10.3736/jcim20100106
26
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statementAutoimmunity Reviews 2017; 16(5): 523 doi: 10.1016/j.autrev.2017.03.004